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Key Points
•Mutations in b spectrin
cause microcytosis,
resulting in increased
clearance of erythro-
cytes and enhanced
resistance to malaria in
mice.
• A homozygous CRISPR/
Cas9-induced mutation
in the binding site be-
tween b spectrin and
ankyrin-1 increases
mouse survival during
malaria.
The malaria parasite hijacks host erythrocytes to shield itself from the immune system and
proliferate. Red blood cell abnormalities can provide protection from malaria by impeding
parasite invasion and growth within the cell or by compromising the ability of parasites to
avoid host clearance. Here, we describe 2 N-ethyl-N-nitrosourea–induced mouse lines,
SptbMRI26194 and SptbMRI53426, containing single-point mutations in the erythrocyte
membrane skeleton gene, b spectrin (Sptb), which exhibit microcytosis but retain a
relatively normal ratio of erythrocyte surface area to volume and are highly resistant to
rodent malaria. We propose the major factor responsible for malaria protection is the
specific clearance of mutant erythrocytes, although an enhanced clearance of uninfected
mutant erythrocytes was also observed (ie, the bystander effect). Using an in vivo
erythrocyte tracking assay, we established that this phenomenon occurs irrespective of host
environment, precluding the involvement of nonerythrocytic cells in the resistance
mechanism. Furthermore, we recapitulated this phenotype by disrupting the interaction
between ankyrin-1 and b spectrin in vivo using CRISPR/Cas9 genome editing technology,
thereby genetically validating a potential antimalarial target. This study sheds new light on
the role of b spectrin during Plasmodium infection and highlights how changes in the
erythrocyte cytoskeleton can substantially influence malaria susceptibility with minimal
adverse consequences for the host.
Introduction
Malaria has exerted the strongest known selective pressure in the recent history of the human genome.1
One of the outcomes of this is a higher prevalence of erythrocytic polymorphisms, which provides
protection against malaria infection.2,3 Studies of the biological mechanisms underlying this protection
have led to an increased understanding of the interactions between host and parasite. For example,
genetic polymorphisms such as Duffy negativity and glycophorin C null mutations, which impair parasite
invasion, have facilitated the identification of parasite proteins involved in this process.4 -6 Studies of
other erythrocyte polymorphisms have shown them to be associated with impaired cytoadherence of
infected cells,7,8 reduced erythrocyte rosetting,9 enhanced phagocytosis of infected cells,10,11
interference with parasite protein trafficking,12 and modulation of parasite protein translation through
microRNAs.13 Mechanisms of resistance in these conditions are multifactorial and diverse and remain
incompletely understood.
Submitted 8 June 2017; accepted 31 October 2017. DOI 10.1182/
bloodadvances.2017009274 .
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Figure 1. Hematological properties of mutant lines MRI26194 and MRI53426. Representative Giemsa-stained smears (A) and standard error of the mean (SEM)
images (B) of erythrocytes from wild-type (WT; 1/1) and both mutant lines. Hematological properties from an automated blood count. (C) Mean cell volume (MCV), mean cell
hemoglobin (MCH), RBC (erythrocyte) count, and hemoglobin (HGB) by volume (n 5 14 -36 per group). (D) Mean values for volume, surface area, ratio of surface area to
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A critical aspect of the lifecycle of Plasmodium is its interaction with
the erythrocyte membrane skeleton, which it manipulates to enter,
develop within, and egress from the erythrocyte.14 Populations in
endemic malaria areas have an increased prevalence of mutations in
skeletal proteins causing hereditary spherocytosis (HS) or hereditary
elliptocytosis (HE).15,16 Southeast Asian ovalocytosis (SAO), a form of
HE caused by a mutation in band 3, is known to reduce rates of
cerebral malaria.17,18 Other studies exploring the potential association
of these conditions with malaria risk are lacking. Ankyrin-1 links the
spectrin-actin cytoskeleton to the red blood cell (RBC)membrane and
band 3 protein. The interaction between ankyrin-1 and spectrin
proteins is essential to maintain the integrity of the RBC.19 The
disruption of this interaction affects the rigidity of RBCs and results in
conditions such as HS, HE, or SAO.20 In vitro studies have
demonstrated impaired invasion and/or growth in erythrocytes from
individuals with HE and HS, indicating a likely role for these mutations
in malaria resistance.21-23 Furthermore, several distinct mutations in
ankyrin-1 (Ank1) and a spectrin (Spta1), associated with HS, have
been shown to convey resistance to P chabaudi and P berghei
infection in mice.24 -27 The mechanisms responsible for reduced
parasite proliferation in vitro or malaria resistance in vivo are poorly
understood in these conditions. The best studied is SAO, where
impaired merozoite invasion of erythrocytes has been proposed as a
protective mechanism conveyed by this condition. It has been
suggested that the loss of merozoite binding partners,28 increased
membrane-skeleton interactions,29 or membrane rigidity30 hinders
invasion of these cells.
To better understand the contribution of the interaction between
spectrins and ankyrin-1 to malaria resistance, we generated and
studied 2 novel N-ethyl-N-nitrosourea (ENU)–induced mutations
in the b spectrin gene (Sptb) in mice. Mutations in Sptb are
associated with both HE and HS; however, the influence of
mutations in Sptb on the course of malaria is unknown. We found
ENU-mutated mice had erythrocytes that were slightly reduced in
size and deformability. Strikingly, these mice were highly resistant to
rodent malaria infection. We showed that this was not due to
reduced parasite invasion; rather, infected Sptb-mutant erythro-
cytes had an enhanced susceptibility to clearance by the host or
maturation defect. To assess the potential of Sptb to influence
malaria susceptibility, we mutated a previously identified31 critical
binding site between b spectrin and ankyrin in mice using CRISPR/
Cas9 genome editing. These mice also displayed a high level of
protection against P chabaudi infection, highlighting the influence
of Sptb in determining malaria susceptibility.
Methods
For detailed descriptions and previously published methods, see
supplemental Data.
Mice and ethics
Experiments were performed on SJL/J mice unless otherwise
stated. Procedures were in accordance with policies of the
Australian National University and National Health and Medical
Research Council Australian code of practice approved under
Ethics No. AEEC 2014 /54 .
ENU mutagenesis and linkage mapping of
causative mutation
ENU mutagenesis and blood screening were performed as
described.24 Mice received 2 intraperitoneal injections of 150 mg/kg
of ENU (Sigma-Aldrich, St Louis, MO), and progeny were screened
for peripheral blood parameters using an Advia 120 hematological
analyzer (Siemens, Berlin, Germany). Causative mutations were
identified by linkage analysis as described.32
Erythrocyte measurements
Light microscopy,32 scanning electron microscopy,27 osmotic
fragility,32 erythrocyte lifespan,32 ektacytometry,33 western blots,27
and in vitro spleen retention assays34 were performed as previously
described. Microfluidic studies were carried out as detailed in
supplementary methods.
IVET assays
In vivo erythrocyte tracking (IVET) assays were performed as
described with modifications.35,36 Briefly, freshly drawn blood was
incubated at 4 °C for 1 hour in 1 of 3 labeling solutions: 6 or 20 mg/mL
of NHS-Atto 633 or 125 mg/mL of Sulfo-LC-NHS-Biotin (Thermo
Fisher Scientific, Waltham, MA). Labeled erythrocytes were
combined and transfused into host mice IV. In some experiments,
host mice were injected with 2 doses of clodronate liposomes (CLs;
4 0 mg/g) IP 24 hours and IV 12 hours before blood sampling to
deplete peritoneal, circulating, and tissue resident cells.37
Flow cytometry
For malaria infections and IVET assays, blood samples were prepared
and analyzed as described with modifications.35,36 Samples were
collected using a BD LSRFortessa or BD Influx flow cytometer (BD
Biosciences, Franklin Lakes, NJ), with analysis performed using FlowJo
software (version 10.0.6; Tree Star, Ashland, OR) as described.35,36
Phagocytosis assays
Blood was collected from infected mice and labeled with 20 mg/mL
of NHS-Atto-633. Resident IP cells were harvested by washing cavities
with 10 mL of ice-cold mouse tonicity phosphate-buffered saline as
previously described.38 Harvested cells were combined with labeled
cells before being allowed to settle onto slides at 37°C for 30 minutes.
Nonadherent cells were removed and bound, and nonphagocytized
erythrocytes were lysed in ice-cold water for 30 seconds.
Generation of SptbD1781R mice using CRISPR/Cas9
genome editing technology
Superovulated SJL/J female mice were mated and embryos
collected and microinjected using a Nikon Eclipse Ti platform
(Nikon, Tokyo, Japan); 5 ng/mL of px4 61 circular plasmid39
Figure 1. (continued) volume, and distance from channel exit of cell populations for WT (3 mice, 64 2 cells) and MRI2694 (2 mice, 233 cells) erythrocytes. (E) Osmotic
fragility of erythrocytes (n 5 8-35 per group). (F) Erythrocyte lifespan (n 5 4 per group); dashed line is 50%. (G) Erythrocyte deformability as measured by ektacytometry
(n 5 3-6 per group). (H) Retention of erythrocytes in an in vitro spleen bead filtration model (n 5 7 per group). Mean and SEM are indicated, except for microfluidic results,
where standard deviation is indicated. Mann-Whitney U test was used to calculate P values. *P , .05, **P , .01, ***P , .001 between MRI26194 and WT. #P , .05,
##P , .01, ###P , .001 between MRI534 26 and WT. NS, not significant.
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(obtained from Addgene and gifted from Zhang Laboratory, ID
4 814 0) and 20 ng/mL of ultramer single-stranded oligonucleotides
(IDT, Singapore) were delivered into fertilized zygotes by pronuclear
injection. The microinjected zygotes were surgically transferred into
8- to 12-week-old pseudoplugged CBA/J 3 SJL/J recipient
females. Founder mice were genotyped for the presence of the
point mutation using Sanger sequencing.
Statistics
For malaria survival, statistical significance was determined by the
Mantel-Cox test. For ratios obtained in the IVET assays, significance
was determined using the 1-sample t test with 1 as the hypothetical
mean. For other results, a 2-tailed Student t test was used.
Results
ENU-induced mutations in Sptb in 2 mouse strains
with a dominant microcytosis phenotype
We established 2 mouse lines from an ENU mutagenesis screen
with a dominant, microcytic inheritance pattern, MRI26194 and
MRI534 26. Despite being microcytic, erythrocytes exhibited a
biconcave shape (Figure 1A-B), and mice displayed no additional
pathological phenotypes or infertility. Hematological analysis revealed
decreased cellular hemoglobin content; however, this was counter-
acted by an increased erythrocyte count, so hemoglobin blood levels
were normal (Figure 1C). Using an HEMA microfluidics device,4 0 we
found that both surface area and volume of MRI26194 erythrocytes
were decreased compared with WT. The ratio of surface area to
volume was slightly decreased for the mutants (Figure 1D). Taken
together, this is consistent with the maintenance of the biconcave disc
shape. MRI26194 erythrocytes also did not progress as far into the
trapping channels (;28% closer to the channel mouth), indicating
reduced cellular deformability (Figure 1D). Mutant erythrocytes were
significantly more osmotically fragile (Figure 1E) and showed an in vivo
half-life reduced by ;25% (Figure 1F). The reduction in mutant-cell
deformability was confirmed using ektacytometry (Figure 1G) and
resulted in .50% of cells retained in an in vitro spleen-mimic filtration
assay (Figure 1H).
We intercrossed microcytic mice to establish a homozygous
phenotype. For MRI26194 , most offspring resembled the parental
or WT erythrocyte phenotype, although a limited number of pups
exhibited jaundice and rapid breathing and lived no longer than 4 8
hours (Figure 2A). Blood smears from these pups revealed severe
erythrocyte fragmentation, spherocytic erythrocytes, and reticulocyto-
sis, indicating these mice were likely homozygous (Figure 2B). For
MRI534 26, offspring displayed only the WT or parental microcytosis
phenotype. Embryo reabsorption was evident as early as E9.5,
suggesting homozygosity for MRI534 26 is lethal early in development.
Linkage mapping and a candidate gene approach lead us to identify
an A→T transversion in the exon 6/intron 7 boundary (IVS612T.A)
of the Sptb gene in the MRI26194 line (supplemental Figure 1). This
mutation, designated SptbMRI26194, is predicted to disrupt splicing
of intron 7 and result in translation of a 188 amino acid residue
truncated protein (Figure 2C). In the MRI534 26-mutant line, a T→A
transversion was identified in exon 4 of Sptb. This mutation,
SptbMRI53426, results in a valine to glutamic acid missense mutation
(V116E; Figure 2C; supplemental Figure 1). The V116 residue is
located within the N-terminal calponin homology domain, which is
involved in binding to erythrocyte b actin.4 1 Analysis using the SIFT
algorithm indicated this amino acid is also conserved across 4 6
species, suggesting the V116E mutation may disrupt a critical
function.4 2 Both mutations completely segregated with the
microcytic phenotype over .10 generations, whereas jaundiced
pups identified in the MRI26194 line were homozygous for the
IVS612T.A mutation. Together these indicate a phenotype
compatible with that seen for HS or HE in human populations.
mRNA and protein expression in Sptb-mutant mice
To explain the observed phenotype of mutant mice, we investigated
the effects of these mutations on messenger RNA (mRNA) and
protein expression. For MRI26194 , quantitative polymerase chain
reaction analysis of embryonic livers from homozygous and
heterozygous mice indicated sufficient b spectrin mRNA expression
(supplemental Figure 2). However, no full-length or truncated
protein was detectable by western blot in protein extracts from the
blood of SptbMRI26194/MRI26194 pups, indicating the mutation
disrupts protein expression or stability (Figure 2D). To investigate
the erythrocyte skeletal composition of the heterozygote mutants,
we examined purified erythrocyte ghosts (supplemental Figure 3) by
Coomassie blue staining and western blot (Figure 2E-G). No major
differences were found in b spectrin abundance or in other major
skeletal proteins (Figure 2E-G). However, there were intense bands
in Coomassie-stained gels for both mutant samples at approxi-
mately 15 kDa, corresponding to a and b globin chains, suggesting
increased membrane-bound hemoglobin (Figure 2E). Together
these data suggest that although homozygous mice do not express
b spectrin protein (in the case of MRI26194 ), heterozygous mice
are able to compensate for the mutated allele and produce
erythrocytes with relatively unperturbed skeletal protein content,
albeit of smaller size.
SptbMRI26194/1 and SptbMRI53426/1 mice are resistant
to rodent malaria infection
Heterozgous Sptb mice inoculated with P chabaudi adami DS,
normally lethal against this parental mouse strain, displayed a
significantly altered course of infection compared with WT mice.
Parasitemia was lower between days 9 and 12, and peak
parasitemia was reduced by .4 0%. These differences were
associated with increased reticulocyte production beginning on
day 9 and a substantial increase in resistance. Over 90% of
Figure 2. The MRI26194 and MRI53426 phenotypes are due to mutations in Sptb. (A) Mating between SptbMRI26194/1 by SptbMRI26194/1 mice occasionally produced
homozygous pups displaying jaundice. (B) Giemsa-stained blood smears from WT and homozygous pups. (C) Schematic of the b spectrin protein indicating different structural
domains, and the locations and predicted effects of the mutations identified in the MRI26194 and MRI534 26 lines. (D) Western blot of whole RBC lysates from homozygous
and WT pups separated by sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) on a 4 % to 20% gel and probed using an antibody against the N-terminal
of b spectrin, with actin and ankyrin-1 as loading controls. The expected size of the truncated b spectrin (24 kD) is indicated with an arrow. (E) Representative image of a
Coomasie-stained SDS-PAGE gel containing erythrocyte membrane preparations from mutant and WT mice. (F) Images of western blots of major skeletal proteins in
erythrocyte membrane preparations from mutant and WT mice. (G) Quantification of protein bands detected by western blot (3 mice per group).
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SptbMRI26194/1 mice (10 of 11) and all of the SptbMR53426/1 mice
(6 of 6) survived the infection, compared with ,9% of WT mice
(1 of 12; Figure 3A).
Mice were also infected with P yoelii NL, which unlike P chabaudi
has a strong preference for reticulocytes. Except in 2 WT mice that
succumbed to infection on days 17 and 19, infection resolved in all
other mice. Parasitemia of mutant mice peaked 2 days earlier (day
13; 18% to 23%) and decreased thereafter, whereas in the WT
mice, it peaked at approximately 32% on day 15 (Figure 3B).
Proportions of infected reticulocytes in all the lines increased rapidly
until day 9 before steadily decreasing; the proportion of mutant
infected reticulocytes was consistently lower than WT during
recovery (supplemental Figure 4 ). Notably, mutant mice had 4 3% to
77% fewer infected mature erythrocytes between days 15 and 17
(supplemental Figure 4 ). Overall, the Sptb-mutant lines displayed
enhanced resistance to both P chabaudi and P yoelii infection,
characterized by earlier and more rapid clearance of parasites.
Increased clearance of Sptb-mutant erythrocytes
during infection
Given the alterations in erythrocyte physiology in the mutant lines,
we considered if resistance to P chabaudi and P yoelii infection was
due to an impaired ability of parasites to infect and grow within
mutant erythrocytes. To address this, an IVET assay was performed
as previously described.35,36 This assay enables direct comparison
of the relative rates of parasite invasion, growth, and clearance in
WT vs mutant erythrocytes. Importantly, within this setting, both
mutant andWT cells are exposed to the same number of potentially
invading merozoites and an identical host response to the infection.
Labeled mutant and WT erythrocytes were transfused into infected
WT mice during the peak of schizogony, with labeled and parasitized
cells differentiated from host cells by flow cytometry (Figure 4 A-B).
Because each host animal presents a different set of environmental
conditions and level of parasitemia, all results are presented as a ratio
relative to WT, with a result of 1 indicating no effect.
Infected labeled cells were detected as soon as 2 minutes after
transfusion of WT and mutant erythrocytes in P chabaudi–infected
host animals, and their frequencies increased during the following
12 hours of monitoring. Relative to WT cells, there were similar or
variably higher proportions of newly infected mutant cells
(Figure 4 Ci). This indicates the rate of merozoite invasion of mutant
cells was normal. In contrast, after 3 and 12 hours, the proportion of
parasitized mutant cells was smaller than that of WT (15% to 16%
and 12% to 17% reduction in SptbMRI26194/1 and SptbMRI53426/1,
respectively). This suggests that once infected, mutant parasitized
cells are cleared more rapidly from circulation. Given the smaller
volume and increased osmotic fragility of the mutant erythrocytes,
this may result from premature rupture of the host cell as the
intraerythrocytic parasite develops. Noting that this reduction
represents the effect of the mutation over a 24 -hour period, we
used a mathematical model to predict the consequential effect on
parasitemia in the mutant animals over the course of an infection
(assuming this difference was similar and additive every 24 hours;
supplemental Figure 5). We found this difference was sufficient to
entirely account for the parasitemia differences observed in both
lines, even at the lowest estimation (12% reduction per 24 hours).
Malaria infection is known to result in accelerated clearance of
uninfected erythrocytes, a phenomenon known as the bystander
effect.4 3 We therefore also compared the relative circulatory
lifespan of the WT vs mutant uninfected cells in the infected host
animals. We observed 10% to 15% fewer mutant cells 30 minutes
after infusion, and this difference was maintained over the 12-hour
period of monitoring (Figure 4 Cii). Notably, this result was not
observed when labeled erythrocytes were transfused into un-
infected mice (supplemental Figure 6). Given the increased fragility
and decreased deformability of the mutant erythrocytes, it is
possible that they are more susceptible to this effect. Overall, both
Sptb mutations result in an erythrocyte autonomous parasite
clearance phenotype, as well as increased bystander cell clearance.
We therefore focused additional experiments on identification of
the mechanism(s) underlying this phenotype.
Phagocytosis in the spleen is responsible for
increased clearance of Sptb-mutant erythrocytes
The spleen plays a central role in malaria immunity4 4 ; in particular, it
selectively removes parasitized cells and directs the development of
secondary immune responses. This occurs both through the
filtration of poorly deformable cells in splenic endothelial slits and
through phagocytosis by resident macrophages. To test if splenic
filtration and/or splenic phagocytosis were required for the cell-
clearance phenotype, the IVET assay was repeated using
splenectomized host mice, which lack splenic filtration and splenic
phagocytosis abilities, and mice treated with CLs, which have been
depleted of splenic as well as nonsplenic phagocytic cells. Neither
the removal of the spleen nor CL treatment had an effect on the
elevated clearance of infected mutant cells (Figure 5Ai-Bi). In line
with this result, splenectomized SptbMRI26194/1 mice infected with
P chabaudi displayed reduced parasitemia vs splenectomized WT
mice (Figure 5C). However, during the IVET assays, the clearance
of all labeled mutant cells (infected or not) was equal to or less than
that of WT (Figure 5Aii-Bii). This was in contrast to the previous
IVET assays, performed with intact host mice. This indicates that
inhibition of phagocytosis alone can prevent the preferential
bystander clearance of uninfected mutant cells.
The spleen can selectively remove parasitized cells based on
decreased cellular deformability.4 4 ,4 5 We observed that compared
with WT erythrocytes, there was greater retention of uninfected
mutant erythrocytes in the in vitro splenic bead filtration assay
(Figure 1H). In separate experiments, we compared the relative
retentions of both infected and uninfected red cells from WT and
mutant animals infected with P chabaudi. Interestingly, despite a
similar increased retention of uninfected mutant cells, passage of
Figure 3. The MRI26194 and MRI53426 Sptb-mutant lines are resistant to P chabaudi adami DS and P yoelii NL infection. Mice were infected with either
P chabaudi (1 3 104 parasites; 7-12 mice per group) (A) or P yoelii (1 3 105 parasites; 8-15 mice per group) (B). Cohorts were analyzed for survival, percentage infected
blood cells (parasitemia), percentage of reticulocytes, and RBC count (as a percentage of RBC count in uninfected mice). Mean and standard error of the mean are indicated.
The log-rank (Mantel-Cox) test was used to calculate P values for survival; Mann-Whitney U test was used otherwise. *P , .05, **P , .01, ***P , .001 between SptbMRI26194 /1
and WT. #P , .05, ##P , .01, ###P , .001 between SptbMRI534 26/1 and WT.
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infected mutant cells through the filtration column was no different
from that of WT (Figure 6Ai-ii). To confirm the susceptibility of
mutant cells to phagocytosis, we next performed an in vitro
phagocytosis assay. Erythrocytes were collected from P chabaudi–
infected mice (Sptb mutant vs WT). Interestingly, frequencies of
phagocytized erythrocytes from both mutant lines were more than
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Figure 4. An IVET assay indicates normal invasion but increased clearance of Sptb-mutant erythrocytes. (A) Host mice were infected with 1 3 104 P chabaudi
parasites. At day 9 to 10 of infection, at the peak of schizogony, labeled blood from the 2 mutant lines and WT (1/1) mice was transfused into host mice (n 5 5). Labels were
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pRBC, parasitized RBC; WBC, white blood cell.
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double those of the WT cells, and this difference was statisti-
cally significant (P 5 .023 and .016 for SptbMRI26194/1 and
SptbMRI53426/1, respectively; Figure 6Bii); however, erythrocytes
isolated from uninfected mutant and WT mice were rarely
internalized, irrespective of Sptb allele (Figure 6Bii). We considered
if phagocytosis was due to enhanced eryptosis or erythrocyte
senescence; however, we found no major differences in terms of
phosphatidylserine exposure, calcium flux, C3 binding, immuno-
globulin G binding, or band 3 aggregation in mutant cells
(supplemental Figure 7). Overall, this supports the hypothesis that
Sptb-mutant erythrocytes have an inherent susceptibility to
phagocytosis during malaria infection, in addition to their decreased
RBC deformability and spleen retention.
CRISPR/Cas9-generated mouse line SptbD1781R/D1781R
with amutation in the ankyrin binding site ofb spectrin
is resistant to malaria
Our results indicated that 2 distinct mutations in Sptb could
positively influence the course of malaria infection. A key function of
b spectrin in the erythrocyte skeletal matrix is its link to ankyrin-1,
facilitated by a small binding pocket between the ZU5 domain of
ankyrin-1 and spectrin repeats 14 -15.31 Therefore, we hypothe-
sized that the disruption of this binding in vivo may convey malaria
resistance. We used CRISPR/Cas9 to target the aspartate 1781
residue demonstrated previously to disrupt the binding between
ANK1 and SPTB.4 6 We successfully induced a dinucleotide
mutation of GA to CG at this position, causing a substitution with
arginine (supplemental Figure 8A). Mice homozygous for this
mutation (SptbD1781R/D1781R) displayed a similar hematological
phenotype to the ENU-mutagenized lines, confirming the impor-
tance of this residue in the erythrocyte skeleton matrix (supple-
mental Figure 8B-D). Importantly, mice exhibited normal fertility and
lived for .18 months without displaying any additional pathological
phenotypes or signs of toxicity. When challenged with P chabaudi,
.70% of SptbD1781R/D1781R mice survived, whereas all WT mice
succumbed to infection (Figure 7Ai). SptbD1781R/D1781R mice also
had reduced parasitemia, increasing more slowly and peaking
approximately 30% lower than that in WT littermates (Figure 7Aii).
We performed the IVET assay using blood collected from
SptbD1781R/D1781R mice and WT littermates and found that, as
was the case for the ENU lines, mutant mice had a significantly
reduced proportion of parasitized erythrocytes, which again only
occurred 11 hours postinjection, indicating an increased clearance
of parasitized mutant cells compared with WT (Figure 7Bi).
However, in contrast to the ENU mutants, no bystander effect
was observed; rather, mutant erythrocytes had a prolonged lifespan
compared with WT (Figure 7Bii).
Discussion
This study presents 3 key findings. First, 2 distinct ENU-induced
mutations in the murine erythrocyte gene Sptb conveyed a
substantial degree of resistance to P chabaudi adami DS and
significantly reduced parasitemia during P yoelii NL infection.
Second, parasite invasion of mutated cells was likely unaffected;
however, the clearance of parasitized mutant erythrocytes was
enhanced. Third, a targeted amino acid residue change within the
ankyrin binding site of b spectrin was also able to convey protection
to P chabaudi infection, without major adverse effects. Despite this
evidence, we were unable to identify a clear mechanism of malaria
resistance or RBC clearance.
Relatively few studies have explored the potential mechanisms by
which changes in the host erythrocyte membrane skeleton may
affect malaria susceptibility. A prevailing view is that parasite
invasion is impeded by skeletal abnormalities.22,23,4 7 However, our
results indicate this is unlikely to be the basis for the resistance
phenotype observed in our study. We observed variably increased
or equivalent rates of merozoite invasion in IVET assays. Instead, our
IVET analyses allowed us to dissect 2 distinct phenomena that may
contribute to the mechanism of resistance. The first is the
increased susceptibility of parasitized mutant cells to be cleared
from the circulation (12% to 17% increase over 12 hours)
because of early maturation arrest or decreased deformability,
which plausibly explains the observed reduction in parasitemia
over the course of infection as indicated by modeling studies
(supplemental Figure 5). Importantly, splenectomy did not affect
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the preferential clearance of infected cells measured in the IVET
assays, indicating a different mechanism is at play compared with
the bystander effect. It seems plausible that parasites have a
growth defect within mutant erythrocytes, rendering them more
susceptible to clearance or inducing premature rupture of the
host cell; however, the mechanism of this clearance or maturation
defect remains elusive and would require a comprehensive
investigation of P chabaudi or P berghei parasite using
microscopy techniques and intravital imaging. This investigation
would be complemented by the assessment of the mechanisms of
resistance to P falciparum from blood of patients with HS or HE
carrying Sptb mutations.
The second finding from our analyses is the preferential disappear-
ance of uninfected mutant cells. This phenomenon, called the
bystander effect, is a well-known and major contributing factor to
severe malarial anemia. Here, we demonstrated the spleen and
macrophages are largely responsible; removal of the organ or these
cells abrogated the effect. The mechanism of cell clearance may be
related to the increased fragility, smaller size, and decreased
deformability of the mutant cells. Notably, mutations in skeletal
proteins causing HS or HE are known to result in loss of surface
area4 8 and reduced erythrocyte deformability, and in severe cases,
they cause spleen sequestration and reduced erythrocyte life-
span.4 8 It seems plausible that during malaria infection, this effect
would be intensified, although this is the only study to date that
specifically demonstrates the role of the spleen in the bystander
clearance of abnormal erythrocytes during malaria.
A major function of b spectrin is its linking of the underlying
membrane skeleton to the cell membrane through binding to
ankyrin. Using CRISPR/Cas9 genome editing technology, we were
able to substitute an aspartate for arginine amino acid in the small
ankyrin binding pocket of b spectrin. We showed not only that this
mutation disrupts erythrocyte stability and deformability as pre-
dicted, but also that homozygous mice were partially protected
against P chabaudi infection. Together with the ENU-mutant lines,
this result indicates allelic heterogeneity at the Sptb locus,
influencing malaria susceptibility, and highlights the importance of
Sptb in the host response to malaria. Importantly, disruption of the b
spectrin/ankyrin binding site through the D1781R mutation, even in
the homozygous case, did not result in any adverse effects, and
mice were able to live and breed normally.
Given the findings of this study, it is of interest to determine if
naturally occurring mutations in SPTB may occur more frequently in
malaria-exposed human populations. Several genome-wide associ-
ation studies have aimed to identify genes associated with malaria
risk. Although SPTB, associated with HE and HS, was included in 1
of these studies,4 9 it was not significantly associated with changes
in the occurrence of severe malaria episodes. The lack of
association may be due to several reasons, including heterogeneity
across study sites, insufficient sensitivity, or population stratification,
and more carefully designed studies should be performed before a
conclusion can be reached regarding the association between
SPTB and malaria resistance in humans.
In conclusion, 2 novel ENU-induced mutations in the erythrocyte
skeletal gene Sptb are reported that protect against malaria. In
contrast to previous studies of erythrocyte membrane skeleton
mutations, parasites were able to invade mutant erythrocytes
normally; however, parasitized erythrocytes were more susceptible
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Figure 7. Mice with a targeted CRISPR mutation in the
ankyrin binding site of b spectrin are resistant to malaria.
Survival (Ai) and parasitemia (Aii) of WT and SptbD1781R/D1781R
mice infected with 1 3 104 P chabaudi parasites. (B) IVET assay
results (as described in Figure 4 ) using SptbD1781R/D1781R- and
WT-labeled erythrocytes. Percentage of infected cells (ratio to 1/1)
(Bi) and remaining cells (ratio to 1/1) (Bii). Mean and standard
error of the mean are indicated. The 1-sample t test was used to
calculate P values for ratios; Mann-Whitney U test was used
otherwise. *P , .05, **P , .01, ***P , .001.
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to clearance. This phenotype was reproduced in mice with a
homozygous CRISPR/Cas9 mutation in the ankyrin binding site of b
spectrin.
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